Byterna Therapeutics Raises Angel Plus Round for cmRNA CAR‑T Pipeline
Byterna Therapeutics completed its angel plus round financing, exclusively invested by Efung Capital. Proceeds will...
Byterna Therapeutics
Sun‑Novo, Byterna, and CAR‑T/CircRNA Collaboration Propel In‑Vivo Gene‑Therapy Frontiers
Beijing Sun‑Novo Pharmaceutical Research Co., Ltd. today disclosed a strategic capital injection of RMB 15 million into...